Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2003, p. 3909-3917, Vol. 23, No. 11
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.11.3909-3917.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
Received 22 November 2002/ Returned for modification 4 February 2003/ Accepted 4 March 2003
|
|
|---|
mutant strains show reduced specific activity in vitro, and affinity-purified Pak1 kinase is able to activate the Snf1-dependent phosphorylation of Mig1 in vitro. Purified Pak1 kinase promotes the phosphorylation of the Snf1 polypeptide on threonine 210 within the activation loop in vitro, and an increased dosage of the PAK1 gene causes increased Snf1 threonine 210 phosphorylation in vivo. Deletion of the PAK1 gene does not produce a Snf phenotype, suggesting that one or more additional protein kinases is able to activate Snf1 in vivo. However, deletion of the PAK1 gene suppresses many of the phenotypes associated with the deletion of the REG1 gene, providing genetic evidence that Pak1 activates Snf1 in vivo. The closest mammalian homologue of yeast Pak1 kinase, calcium-calmodulin-dependent protein kinase kinase beta, may play a similar role in mammalian nutrient stress signaling. |
|
|---|
Biochemical and genetic experiments have shown that members of the Snf1/AMP-activated protein kinase family are regulated by phosphorylation of the conserved threonine residue in the kinase activation loop. This mechanism for controlling protein kinase activity is used both by members of the serine threonine protein kinase family and by members of the tyrosine protein kinase family. Biochemical fractionation of rat liver has shown that threonine 172 of the mammalian AMPK enzyme is phosphorylated by a distinct protein kinase called AMPK kinase (AMPKK) (11). In budding yeast, the analogous threonine is located at position 210. Carlson and coworkers first showed that replacement of this residue with alanine inactivates Snf1 (5), suggesting that phosphorylation of Snf1 threonine 210 is required for Snf1 activation. Later, Hardie and colleagues demonstrated that Snf1 is regulated by phosphorylation of its activation loop threonine (37). Despite intensive study, the identity of the Snf1-activating kinase has not been determined. One possible explanation for this is that the Snf1 kinase catalyzes the autophosphorylation of threonine 210. An autophosphorylation event would explain the failure to identify a Snf1-activating kinase in genetic screens. More recently, we developed a phosphopeptide antibody that is specific for the Snf1 protein that has been phosphorylated on threonine 210 (21). By using this antibody, we have shown that phosphorylation of Snf1 threonine 210 correlates with glucose stress and Snf1 kinase activation. Further, phosphorylation of threonine 210 occurs normally in cells lacking a functional Snf1 kinase. Therefore, Snf1 kinase must be activated by an upstream kinase.
Recently, genomic studies of yeast protein complexes have used mass spectrometry to identify proteins in hundreds of affinity-purified complexes (6, 14). Affinity purification of protein complexes with tagged versions of the Snf1 and Snf4 proteins led to the identification of several other proteins that may be present in a complex with Snf1 kinase. Not surprisingly, the beta and gamma subunits of Snf1 kinase (Snf4, Sip1, Sip2, and Gal83) were identified as members of the Snf1 complex. More interesting was the finding that two protein kinases, Pak1 and Cka1, are also associated with either Snf1 or Snf4 (6). PAK1 (polymerase alpha kinase 1) was isolated in a screen for multicopy suppressors of a temperature-sensitive mutation in CDC17, the gene encoding DNA polymerase alpha (15), however, a direct connection between Pak1 and DNA polymerase alpha was not demonstrated. Pak1 is likely to be a Snf1 kinase complex component since it was found independently in complexes isolated with both Snf1 and Snf4 as the tagged proteins (6) and since Pak1 was not found in association with any other proteins. The gene for protein kinase Cka1 is one of two yeast genes that encode orthologues of mammalian casein kinase II. The significance of the purported interaction between Cka1 and the Snf1 kinase complex is questionable since Cka1 was found to be present in several complexes of disparate functions (6, 14). Finally, analysis of proteins associated with protein kinase Tos3, a close homologue of Pak1, identified several proteins, including Snf4, the gamma subunit of the Snf1 kinase (14). The significance of this interaction is also questionable since no other Snf1 kinase components were detected in association with Tos3. In this study, we investigated the possibility that Pak1, Tos3, or Cka1 directly activates Snf1 by phosphorylation of the threonine residue in the Snf1 activation loop.
We focused on the Pak1 protein kinase since it was found in the Snf1 complex with both Snf1 and Snf4 as the tagged proteins. Furthermore, the closest mammalian homologue of Pak1 is calcium/calmodulin-dependent protein kinase kinase beta (CaMKK-ß), a kinase known to phosphorylate and activate other protein kinases (1). The closest mammalian homologue of Tos3 is CaMKK-
. Pak1 and Tos3 are members of the calcium/calmodulin-dependent kinase family, which includes the Cmk1 and Snf1 kinases (16). The name PAK1 can be somewhat confusing since a distinct and much larger body of literature uses the term PAK to refer to p21-activated kinases. Several mammalian kinases in the p21-activated kinase family go by the name PAK1, as does a PAK-encoding gene in Schizosaccharomyces pombe (17, 34). To make matters even more confusing, another yeast kinase gene, PRK1 (YIL095w), was once annotated as PAK1 (32). The net result of the presence of multiple names for the same genes and different genes with the same name is that the many databases contain incorrect annotations for these genes. Lest there be any confusion, this report concerns the product of Saccharomyces cerevisiae gene PAK1 encoded by open reading frame YER129w.
|
|
|---|
1 trp1
63 his3
200), FY1193 (MAT
ura3-52 leu2
1 trp1
63 his3
200 snf1
10), MSY608 (MATa ura3
0 leu2
0 his3
1 met15
0 kin1::KAN), MSY678 (MAT
ura3
0 leu2
0 his3
1 met15
0 pak1::KAN), MSY809 [MATa ura3(52/
0) leu2(
1/
0) his3(
1/
200) trp1
63 met15
0 snf1
10 pak1::KAN], MSY839 [MAT
ura3(52
0) leu2
0 lys2
0 trp1
63 reg1
::URA3 pak1
::KAN], PY102 (MATa his9-917
lys2 leu2
1 ura3-52 trp1
63 reg1
::URA3), and PY450 (MAT
ura3-52 leu2
1 trp1
63 his3
200 reg1
::URA3 snf1
10). Plasmids. The PAK1 gene was cloned from a plasmid library of yeast genomic DNA by screening pools of bacterial clones by PCR (28). A 5.7-kb fragment (MunI-EagI) encompassing the entire PAK1 gene was subcloned into pRS424 (29) and designated pPAK1-424. The tandem affinity purification tag (25) was amplified by PCR and introduced into the 3' end of the PAK1 gene in pPAK1-424 by homologous recombination. Pak1 was tagged at the C terminus with three copies of the myc epitope with plasmid pYM3 (36), PCR amplification, and homologous recombination. Clones of yeast cells expressing GST-Cka1 and GST-Tos3 (19) were isolated from pools of transformants by PCR prior to use. A plasmid expressing glutathione S-transferase (GST)-Mig1 in Escherichia coli has been described previously (22).
Western blotting. Tagged proteins were detected by Western blotting under conditions described previously (21). Mouse monoclonal antibodies against the hemagglutinin (HA; F7) and myc (9E10) epitopes were purchased from Santa Cruz Biotechnology. Antibodies against Snf1 protein phosphorylated on threonine 210 have been described previously (21). Antibodies were incubated with membranes for 2 h at a dilution of 1/1,000, except for the myc antibody, which was used at a dilution of 1/250 and incubated with membranes overnight.
Immunoprecipitation.
Protein extracts were prepared from snf1
10 pak1
(MSY809) cells transformed with empty plasmid vectors or with plasmids expressing Snf1-3HA or Pak1-3myc. Snf1 complexes were collected from 800 µg of total protein by incubation with 2.5 µl of undiluted monoclonal antibodies against HA for 1.5 h at 4°C and then incubated with 20 µl of protein A beads (Sigma). The beads were washed three times with radioimmunoprecipitation assay buffer, and bound proteins were eluted by incubation in sodium dodecyl sulfate (SDS) sample buffer at 95°C.
In vitro kinase assays.
Protein kinase assay mixtures contained 0.2 mM [
-32P]ATP (1,000 cpm/pmol) in 20 µl of kinase buffer (20 mM HEPES [pH 7.0], 0.5 mM EDTA, 0.5 mM dithiothreitol, 5 mM Mg acetate) and were incubated at 30°C for 20 min. Substrate proteins (GST-Mig1) were present at approximately 10 µg/ml. Snf1 kinase was added to autophosphorylation reaction mixtures at a final concentration of approximately 25 ng/ml. When GST-Mig1 was present as the phosphate acceptor, Snf1 kinase was added to a final concentration of 2.5 ng/ml. Proteins were precipitated on ice with 200 µl of 10% trichloroacetic acid, washed in ice-cold acetone, and resolved by SDS-polyacrylamide gel electrophoresis. Incorporation of 32P was detected by autoradiography of dried gels.
Protein purification. Snf1 kinase complexes were isolated from cultures grown on sucrose medium by tandem affinity purification (25), followed by Mono Q chromatography as previously described (22). Pak1 kinase was purified by tandem affinity purification (25). GST-Cka1 and GST-Tos3 were purified by glutathione agarose chromatography (24).
|
|
|---|
![]() View larger version (28K): [in a new window] |
FIG. 1. Pak1 kinase, but not Cka1 or Tos3, promotes phosphorylation of Snf1 in vitro. (A) Reaction mixtures contained [ -32P]ATP and additional purified proteins as indicated. Phosphorylated products were detected by autoradiography. (B) Pak1 kinase-dependent phosphorylation of Snf1 kinase components. A limiting concentration (2.5 ng/ml) of Snf1 kinase purified from pak1 mutant cells (lanes 1 to 4) was incubated with either no Pak1 or increasing concentrations of Pak1 kinase purified from snf1 10 mutant cells. Snf1 kinase was omitted from the reaction mixture in lane 5.
|
![]() View larger version (45K): [in a new window] |
FIG. 2. Pak1 kinase associates with active Snf1 kinase in vivo. Yeast strain MSY809 (snf1 pak1 ) was transformed simultaneously with two plasmids, either an empty vector (-) or a plasmid expressing Snf1-HA or Pak1-myc, as indicated above each lane. Protein extracts were prepared from cells grown in medium containing 2 or 0.05% glucose. Snf1 kinase complexes were immunoprecipitated (IP) with an anti-HA monoclonal antibody and probed by Western blot assay with anti-myc antibodies (top panel). Equivalent aliquots of each protein extract (20 µg) were analyzed directly by Western blotting with anti-myc (middle panel) and anti-HA (bottom panel) antibodies.
|
mutant cells.
To assess the impact of Pak1 on Snf1 kinase activity, the Snf1 kinase was affinity purified from PAK1 and pak1
mutant cells. The pak1
mutant strain used in this experiment was a haploid segregant from the homozygous deletion strain set (7). Because of concerns about differences caused by different strain backgrounds, we used a related haploid PAK1 mutant strain as our control (haploids MSY608 and MSY678 were derived from Research Genetics strains 31628 and 34056, respectively). Western blotting established that equivalent amounts of Snf1 protein were recovered from both preparations (Fig. 3A). When Mono Q fractions containing Snf1 kinase complexes were incubated with [
-32P]ATP, radioactivity was incorporated into three bands (Fig. 3B). On the basis of results reported previously (22), we have identified two of these bands as Sip2/Gal83 and Snf1. The beta subunits Sip2 and Gal83 were prominently labeled with 32P. These proteins comigrated on SDS gels and appeared as a single band. The third beta subunit, Sip1, was much less abundant (22) and was faintly visible in some reaction mixtures (Fig. 1, lane 2).The Snf1 polypeptide was also labeled with 32P; however, label incorporation was greatly reduced when Snf1 complexes were purified from pak1
mutant cells (Fig. 3B, compare lanes 2 and 7). Finally, a third band of approximately 110 kDa was also labeled. Putative members of the Snf1 kinase complex that are in this size range are Reg1 and Pak1 (14). The 110-kDa protein cannot be the Pak1 protein itself since it is detected in Snf1 complexes purified from pak1
mutant cells. The possibility that the 110-kDa protein is Reg1 is addressed below. Assuming that the abundance of the 110-kDa protein correlates with its 32P incorporation, this protein was present in the Mono Q input (Fig. 3B, lanes 1 and 6) and in the later fractions from the Mono Q column but absent from early Mono Q column fractions (Fig. 3B, lanes 2 and 7). Thus, Snf1 kinase complexes of differing protein compositions may be separated by Mono Q chromatography. Two forms of the Snf1 kinase complex, those with abundant 110-kDa protein (fraction 19) and those lacking the 110-kDa protein (fraction 17), were incubated with [
-32P]ATP, and the labeled proteins were analyzed side by side (Fig. 3C). First, Snf1 kinase complexes from both fractions showed an almost complete loss of incorporation of 32P into the Snf1 polypeptide when the enzyme was purified from pak1
mutant cells. Second, a reduction in overall 32P incorporation was observed in reaction mixtures containing the 110-kDa protein (fraction 17 versus fraction 19).
![]() View larger version (41K): [in a new window] |
FIG. 3. Effect of PAK1 on the activity of purified Snf1 kinase. (A) Western blot assay of Snf1 protein purified from PAK1 and pak1 mutant cells (22). Input and peak fractions across the NaCl gradient of the final Mono Q column were probed with anti-HA antibodies. (B) Input and peak fractions across the NaCl gradient of the final Mono Q column were incubated with [ -32P]ATP and resolved by SDS-polyacrylamide gel electrophoresis. Incorporation of radioactivity was detected by autoradiography (C) Equivalent aliquots from fractions 17 and 19 prepared from PAK1 and pak1 mutant cells were incubated with [ -32P]ATP and resolved side by side on an SDS-polyacrylamide gel.
|
mutant strains. The 110-kDa protein was not detected in reaction mixtures with Snf1 purified from reg1
mutant cells (Fig. 4A) even though equivalent levels of Snf1 enzyme were present (Fig. 4B). The simplest explanation for this is that the 110-kDa protein is the Reg1 protein. We have previously shown that the Reg1 protein is required to remove the activating phosphorylation of threonine 210 (21). Further support for the conclusion that Reg1 is the 110-kDa protein is the observation that fractions with an abundance of the 110-kDa band have lower Snf1 kinase specific activity (Fig. 5A, compare titrations of fractions 17 and 19). We noted also that very little 32P was incorporated into the Snf1 protein purified from reg1
mutant cells (Fig. 4A). Failure to incorporate 32P into Snf1 may be due to the fact that threonine 210 is already fully phosphorylated. Western blotting experiments demonstrated that the Snf1 protein was present in the complex purified from reg1
mutant cells (Fig. 4B) but was not efficiently phosphorylated in vitro.
![]() View larger version (42K): [in a new window] |
FIG. 4. Snf1 kinase complexes contain Reg1 protein. Snf1 kinase complexes prepared from REG1 and reg1 mutant cells were assayed for autophosphorylation activity. Increasing concentrations of Snf1 kinase from the reg1 mutant cells were used (lanes 1 to 3). Lanes 2 and 4 contain comparable levels of Snf1 protein (approximately 25 ng/ml).
|
![]() View larger version (54K): [in a new window] |
FIG. 5. Pak1-dependent activation of Snf1 kinase activity. (A) Increasing concentrations of Snf1 kinase complexes (fractions 17 and 19) were incubated with [ -32P]ATP and recombinant GST-Mig1 protein. Incorporation of radioactivity into the GST-Mig1 protein (and its proteolytic fragments) was detected by autoradiography. Snf1 kinase had been purified from PAK1 (lanes 1 to 3 and 7 to 9) and pak1 (lanes 4 to 6 and 10 to 12) mutant cells. (B) Increasing concentrations of Snf1 kinase purified from pak1 mutant cells (fraction 17) were incubated with [ -32P]ATP, GST-Mig1 protein, and either buffer (lanes 1 to 3) or purified Pak1 kinase (lanes 4 to 6). Snf1 kinase was omitted from one reaction mixture (lane 7).
|
mutant cells showed significantly lower levels of in vitro kinase activity than did an equivalent amount of Snf1 purified from PAK1 cells (Fig. 5A). Snf1 kinase is much more active when assayed with GST-Mig1 as a phosphate acceptor, allowing the use of 10-fold-less Snf1 enzyme. Thus, the autophosphorylation products shown in earlier figures are not observed unless much longer exposures are shown. The Mig1 protein is a known Snf1 target, with four serine residues that are phosphorylated by Snf1 in vivo (33) and in vitro (30). Peak Snf1 complex fractions that lacked Reg1 (fraction 17) or contained abundant Reg1 (fraction 19) were assayed. Deletion of PAK1 led to greatly reduced Snf1 kinase specific activity (compare lanes 1 to 3 with lanes 4 to 6). Equivalent levels of Snf1 protein were included in these reaction mixture, as judged by Western blotting (Fig. 3A). We concluded that Snf1 kinase requires PAK1 for maximal activity.
Purified Pak1 kinase activates Snf1 in vitro.
To determine if the Pak1 kinase could activate Snf1 in vitro, Pak1 kinase was affinity tagged and purified from snf1
10 mutant cells (25). The Snf1 kinase was purified from pak1
mutant cells and showed a low but detectable level of kinase activity in vitro (Fig. 5B). Addition of purified Pak1 kinase significantly increased Snf1 kinase activity, as judged by the level of GST-Mig1 phosphorylation (compare lanes 4 to 6 with lanes 1 to 3). In the absence of added Snf1 kinase, no phosphorylation of GST-Mig1 was observed, demonstrating that Pak1 itself does not phosphorylate GST-Mig1 (lane 7). Thus, Pak1 kinase is able to stimulate Snf1-dependent phosphorylation of GST-Mig1.
Genetic manipulation of PAK1.
Our data support the idea that the Pak1 kinase is a Snf1-activating kinase. This hypothesis was examined genetically by phenotypic analysis of pak1
mutant strains. Our source for the pak1
::KAN allele was the homozygous diploid deletion collection (7). Haploid progeny of strain 36128 were crossed into our own strain background, and tetrads were analyzed for Snf phenotypes. None of our pak1
mutant strains exhibited even a weak Snf phenotype. All pak1
mutant strains grew as well as wild-type cells on raffinose-antimycin medium (Fig. 6A) and on glycerol-ethanol medium at 15, 30, and 37°C. We tested whether deletion of PAK1 could exacerbate the weak Snf phenotype observed in the sip2
gal83
mutant strain. Deletion of PAK1 did not affect the Snf phenotype of this strain (data not shown). All pak1
mutant strains were able to induce invertase expression with normal kinetics and to similar degrees (Fig. 6B). We also crossed our pak1
mutant strains with several other strains bearing deletions of other kinases that are candidates for being Snf1-activating kinases (CKA1, CKA2, TOS3, PKH1, PKH2, KIN1, KIN2, NPR1, et al.). None of the double mutants produced a synthetic Snf phenotype. We also examined the effect of an increased PAK1 gene dosage. A wild-type allele of PAK1 and a kinase-dead allele (D277A) were introduced into both wild-type and pak1
mutant cells on high-copy-number plasmids. In neither case was any change in growth on alternative carbon sources (data not shown) or invertase expression detected (Fig. 7C).
![]() View larger version (27K): [in a new window] |
FIG. 6. Suppression of reg1 by deletion of PAK1. (A) Growth phenotypes were determined by spotting serial dilutions of yeast cultures on YEPD (26), sucrose medium containing 2-deoxyglucose (2DG), and raffinose medium. The relevant genotypes of the yeast strains are shown on the left. (B) Invertase expression of cells grown in 2 or 0.05% glucose (Glu). The relevant genotypes of the yeast strains are shown on the bottom. The mean invertase expression from three independent cultures is plotted. Errors bars represent one standard error. WT, wild type; OD, optical density.
|
![]() View larger version (22K): [in a new window] |
FIG. 7. Pak1 phosphorylates Snf1 on activation loop residue threonine 210. (A) Reaction mixtures contained Snf1 kinase purified from pak1 mutant cells (lanes 1 to 4), Pak1 kinase purified from snf1 10 mutant cells (lanes 3 to 6), and ATP (lanes 2, 4, and 6). Products of the reaction were resolved on an SDS-polyacrylamide gel, transferred to a nylon filter, and probed first with an antibody specific for Snf1 protein containing phosphorylated threonine 210 (21). Both short (top panel) and long (middle panel) exposures of this Western blot are shown ( -PT210). Total Snf1 protein was detected by reprobing the same filter with an antibody directed against the HA epitope ( -HA). (B) Yeast strains expressing HA-tagged Snf1 were transformed with high-copy-number plasmid pRS424 (vector), pPAK1-424 (WT), or pPAK-D277A (D277A), as indicated. Snf1 kinase was immune precipitated from protein extracts prepared from cultures grown in high glucose (2%) and probed by Western blotting with antibodies specific for phosphorylated threonine 210 ( -PT210) or the HA epitope ( -HA). (C) Cells with and without SNF1 were transformed with a high-copy-number plasmid containing either no insert (V) or full-length PAK1. Cells were collected from log-phase cultures grown in 2% (open bars) or 0.05% (filled bars) glucose and assayed for invertase activity. The mean invertase activity (milliunits per unit of optical density [OD]) from three independent transformants is plotted. Error bars represent one standard error.
|
by pak1
.
We did detect genetic interaction between pak1
and reg1
. The Reg1 protein is one of the regulatory subunits of type 1 protein phosphatase Glc7 (35). The Reg1-Glc7 complex acts in opposition to the Snf1 signaling pathway by promoting the dephosphorylation of Snf1 threonine 210 (21). On glucose medium, reg1
mutant strains exhibit derepressed levels of invertase and galactokinase (20, 23) and form small colonies (4). Both phenotypes are Snf1 dependent. If Pak1 kinase is one of the Snf1-activating kinases, then deletion of the PAK1 gene might suppress some or all of the Snf1-dependent phenotypes observed in reg1
mutant strains. To test this prediction, we crossed pak1
and reg1
mutant strains and characterized the phenotypes of the pak1
reg1
double mutant. We found that deletion of PAK1 effectively suppressed a number of the phenotypes of reg1
. First, reg1
mutant cells grown on glucose medium formed small colonies and this phenotype was suppressed by deletion of PAK1 (Fig. 6A). Wild-type cells are unable to grow on sucrose medium in the presence of 2-deoxyglucose (23). Deletion of REG1 causes constitutive relief of glucose repression and allows cells to grow on sucrose medium in the presence of 2-deoxyglucose. Deletion of PAK1 severely restricted the ability of reg1
mutant cells to grow on 2-deoxyglucose medium (Fig. 6A). In addition, the constitutive invertase expression observed in reg1
mutant cells was partially suppressed in reg1
pak1
mutant cells (Fig. 6B). Therefore, pak1
suppresses many of the Snf1-dependent phenotypes observed in reg1
mutant cells. Pak1 phosphorylates Snf1 on threonine 210. Previous studies have shown that the key regulatory phosphorylation site on the Snf1 protein is threonine 210 within the activation loop (5, 21). To determine whether Pak1 phosphorylates Snf1 on threonine 210, we used a phosphopeptide antibody that specifically recognizes Snf1 that has been phosphorylated on threonine 210 (21). Purified Snf1 kinase was incubated with or without ATP in the presence or absence of Pak1 kinase (Fig. 7A). Increased phosphorylation of threonine 210 was detected only when both Pak1 and ATP were present. Therefore, Pak1 kinase promotes the phosphorylation of threonine 210. We next tested whether manipulation of the PAK1 gene copy number affects the phosphorylation of Snf1 threonine 210 in vivo (Fig. 7B). Strains expressing Snf1-HA were transformed with a high-copy-number plasmid with either no insert (2µm vector) or full-length PAK1 (2µm PAK1). Protein extracts were prepared in duplicate from cells grown under high-glucose conditions (2% glucose), and the Snf1 polypeptide was collected by immune precipitation with anti-HA antibodies. Snf1 protein was then detected by parallel Western blot assays with antibodies directed against Snf1 phosphorylated on threonine 210 or against the HA epitope, as indicated. Increased PAK1 gene dosage resulted in a significant increase in the level of phosphorylated threonine 210. Equivalent levels of total Snf1 polypeptide were present in all four extracts (lanes 1 to 4). To determine whether Pak1 kinase activity is required, a point mutation was introduced into the PAK1 gene such that the catalytic aspartate residue was changed to alanine (D277A). Cells transformed with a high-copy-number PAK1 plasmid with a wild-type (WT) kinase domain and cells transformed with a kinase-dead (D277A) high-copy-number PAK1 plasmid were compared. Pak1-mediated stimulation of Snf1 threonine 210 phosphorylation required an intact Pak1 kinase domain (compare lanes 5 and 6). However, increased phosphorylation of Snf1 threonine 210 was not sufficient to activate Snf1, as judged by invertase assays (Fig. 7C). Taken together, our data indicate that the Pak1 kinase activates the Snf1 kinase by phosphorylation of the Snf1 activation loop in vitro and in vivo.
|
|
|---|
mutant strains has a lower specific activity than Snf1 kinase purified from PAK1 mutant strains (Fig. 5A). Taken together, these data demonstrate that Pak1 is a Snf1-activating kinase. Our current model for the phosphorylation events occurring in the Snf1 kinase complex is presented in Fig. 8.
![]() View larger version (23K): [in a new window] |
FIG. 8. Model of Pak1-dependent activation of Snf1 kinase. In the presence of a high glucose concentration, Snf1 kinase is in a complex with the Reg1 protein, which recruits protein phosphatase Glc7 (not shown). The Reg1/Glc7 complex dephosphorylates Snf1 threonine 210 (21). In the presence of a low glucose concentration, Pak1 associates with the Snf1 kinase complex and phosphorylates Snf1 on threonine 210. Snf4 also participates in activation of the Snf1 kinase through direct interaction with the Snf1 regulatory domain. Once activated, Snf1 kinase phosphorylates its beta subunit (Sip1, Sip2, or Gal83), the Reg1 protein, and additional substrates, such as Mig1 (not shown).
|
allele does not produce any detectable Snf phenotype. We cannot formally rule out the possibility that Pak1 is a kinase whose in vivo function is to activate kinases other than Snf1. However, the findings that Pak1 associates with Snf1 in vivo under conditions in which Snf1 is active and that Pak1 promotes phosphorylation of Snf1 threonine 210 in vivo argue against this interpretation. Furthermore, we show that deletion of PAK1 suppresses the phenotypes associated with reg1
. The Reg1-Glc7 PP1 phosphatase is known to act in opposition to Snf1 kinase. Deletion of REG1 results in constitutively activated Snf1. The observation that the pak1
mutation suppresses the phenotypes caused by the reg1
mutation argues strongly that Pak1 is one of the Snf1-activating kinases in vivo. We favor the interpretation that activation of Snf1 kinase is a redundant function that is shared between Pak1 kinase and one or more other kinases. Hartwell and colleagues have pointed out that redundancy is an important source of buffering genetic variation (10). Many yeast genes have one or more paralogues that may mask phenotypes caused by mutations. In the case of Pak1, the closest relative is Tos3 (16); however, the pak1
tos3
mutant strain is also Snf+ (data not shown). Identification of the other putative Snf1-activating kinase(s) would settle the question unambiguously and is a high priority for our future studies. An increased PAK1 gene dosage leads to increased phosphorylation of Snf1 threonine 210 under glucose-repressing conditions but does not lead to activation of Snf1 kinase. Previously, we showed that activation of Snf1 kinase is a two-step process (21). We conclude that phosphorylation of Snf1 threonine 210 is required but not sufficient for Snf1 activation. The PAK1 gene was first isolated in a screen for high-copy suppressors of the temperature sensitivity phenotype caused by the cdc17-1 mutation (15). POL1 (also known as CDC17 or HPR3) encodes one subunit of the alpha DNA polymerase-primase complex. An increased PAK1 copy number partially suppresses the temperature sensitivity phenotype caused by several alleles of POL1. However, a direct connection between Pak1 and DNA polymerase alpha was not established. Furthermore, an increased PAK1 gene dosage did not suppress mutations in other DNA polymerases or even other mutations affecting DNA polymerase alpha. The ability of PAK1 to suppress the cdc17-1 allele required a functional kinase domain. We show here that Pak1 kinase is able to phosphorylate the activation loop threonine of Snf1 kinase (Fig. 7). In addition, the mammalian homologues of Pak1 also activate downstream kinases by phosphorylation of activation loop residues. These observations suggest that Pak1 suppressed the cdc17-1 allele by activating a downstream kinase. It is unlikely that Pak1 is devoted to Snf1 activation. Some other in vivo target of Pak1 might provide an explanation of its ability to suppress mutations affecting the alpha DNA polymerase-primase complex.
Independent experiments demonstrate that Pak1 associates with the Snf1 kinase complex in vivo. In mass spectrometry studies of proteins associated with TAP-tagged Snf1 and TAP-tagged Snf4, both detected Pak1 as a complex member (6). We used myc-tagged Pak1 and HA-tagged Snf1 to demonstrate the association of these proteins by coimmunoprecipitation (Fig. 2). In the course of that experiment, we found that Pak1 accumulation increased under conditions of glucose limitation. A similar increase in Pak1 mRNA was not detected in microarray experiments (3, 18), suggesting that the increase in Pak1 protein abundance may reflect posttranscriptional regulation. Also, a shift in the SDS-polyacrylamide gel mobility of the Pak1 protein in response to glucose limitation was observed, suggesting that the activity or abundance of Pak1 may be regulated by a posttranslational modification.
The mammalian homologue of Snf1 kinase, AMPK, is the subject of intense study, in part because of its potential as a target for treatment of type II diabetes (12). Biochemical studies have shown that AMPK is activated by a distinct protein kinase designated AMPKK (11). The identity of AMPKK has not been determined. Our finding that Pak1 kinase is one of the Snf1-activating kinases in yeast suggests that the mammalian homologue of Pak1, CaMKK-ß, may play a similar role in mammalian cells. Biochemical properties of AMPKK and CaMKK-ß were used to argue that these enzymes are distinct (13). However, this study based its conclusion on efficiency of activation and relied on partially purified fractions containing AMPKK and CaMKK-ß. In some studies, CaMKK-ß has been used as a surrogate AMPKK since recombinant CaMKK-ß is able to phosphorylate the activation loop threonine of AMPK in vitro (8). Full activation of AMPK may involve more than one phosphorylation event (31). Perhaps efficient activation of AMPK requires the action of more than one kinase enzyme, a possibility that may explain the difficulty with the purification and identification of a single AMPKK. Our data suggest that CaMKK-ß may participate in the activation of AMPK in vivo by phosphorylation of the activation loop threonine.
We thank Karen Arndt and Tom Smithgall for thoughtful discussions, Peg Shirra for the reg1
mutant strains, Eric Phiziky and Martha Cyert for providing GST-tagged kinases, and Anna Leech for technical assistance.
|
|
|---|
1 subunit. Biochem. Biophys. Res. Commun. 293:892-898.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»